Yesterday, on
Through the Transaction, the Company mainly acquires intellectual property rights, know-how and operating assets for the distribution and sale of health products containing omega-3, collagen, and astaxin (the "New Business"). The New Business has been assessed by the Company to have a large growth potential in a fast-growing market for health products that is estimated to be worth billions of dollars.
About Omega 3, collagen and astaxin
Omega 3 is a well-known dietary supplement. Omega 3 is a family of polyunsaturated fatty acids that are important for several functions of the human body. Most of the fats the body needs can be formed from carbohydrates and protein. The exception is, among others, some Omega 3 fats, which we must get from food. Omega 3 has many different roles in the body, including building and repairing cells. It also affect the regulation of blood pressure, the functioning of the kidneys and our immune system. Omega 3 reduces the blood's ability to clot, thus reducing the risk of blood clots. For foetuses and young children, Omega 3 is essential for normal growth and development. Polyunsaturated fats can also help reduce the risk of cardiovascular disease.
Collagen is a protein that is an important component of skin, nails, hair, joints, and bones and one of the main benefits of collagen is that it can help improve skin elasticity and prevent wrinkles and ageing. In addition, collagen can also increase the strength and quality of hair and nails.
Astaxin is an antioxidant found naturally in some microalgae and marine animals. The antioxidant properties of astaxin can help protect the body's cells from oxidative stress and damage. It can also have positive effects on vision and brain health, while reducing inflammation in the body and improving muscle recovery after exercise.
Additional information on acquired business activities
The products that QuiaPEG will receive access to through the Transaction are approved and tested by the
Market
The global market for Omega 3 is in strong growth and in 2022 the market was estimated to have a turnover of about
Since health supplements are not regulated in the same way as pharmaceuticals, it is considered particularly important to be able to prove the quality and effects of the products during continuous use and thus build strong brands. It is in this strong market growth that the Company wants to take a position based on pre-proven products produced in
Production
The products will be manufactured in
Sales plan for the products
QuiaPEG sees significant potential in the increased trade in retail and sales of, among other things, health food products on digital platforms such as Amazon. If the Transaction is completed, the focus will be on sales in strategic markets, with
© Modular Finance, source